Pharmacokinetic and Exposure Response Analysis of the Double-Blind Randomized Study of Posaconazole and Voriconazole for Treatment of Invasive Aspergillosis

BACKGROUND AND OBJECTIVE: A double-blind phase 3 study was conducted to compare posaconazole 300 mg intravenously (IV)/300 mg orally once daily (twice daily day 1) with voriconazole 4 mg/kg IV twice daily/200 mg orally twice daily (6 mg/kg day 1) for treatment of invasive aspergillosis. This analysi...

Descripción completa

Detalles Bibliográficos
Autores principales: Maertens, Johan A., Rahav, Galia, Lee, Dong-Gun, Haider, Shariq, Ramirez-Sanchez, Isabel Cristina, Klimko, Nikolai, Ponce-de-León, Alfredo, Han, Seongah, Wrishko, Rebecca, Winchell, Gregory A., Grandhi, Anjana, Waskin, Hetty
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514181/
https://www.ncbi.nlm.nih.gov/pubmed/37676612
http://dx.doi.org/10.1007/s40261-023-01282-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514181/
https://www.ncbi.nlm.nih.gov/pubmed/37676612
http://dx.doi.org/10.1007/s40261-023-01282-7

Ejemplares similares